Schedule 13G ownership disclosure

AtriCure Inc

Common Stock · CUSIP: 04963C209

Event date: 2025-03-31

Filing-level shares
2,137,963.00
Percent of class
4.4%
  • Champlain Investment Partners, LLC

    Shares: 2,137,963.00 · Class: 4.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001315478-25-000017
Form type
SCHEDULE 13G
Filer
AtriCure, Inc.
CIK
CIK 1323885
Filed
May 14, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub